ZNF101 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.337800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.605200E-01
Normal-vs-Stage2
4.403200E-01
Normal-vs-Stage3
3.769200E-01
Normal-vs-Stage4
4.225600E-01
Stage1-vs-Stage2
8.447800E-01
Stage1-vs-Stage3
2.228600E-01
Stage1-vs-Stage4
6.589600E-01
Stage2-vs-Stage3
1.765680E-02
Stage2-vs-Stage4
5.571600E-01
Stage3-vs-Stage4
1.512160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.396000E-01
Normal-vs-AfricanAmerican
4.356600E-01
Normal-vs-Asian
3.676000E-01
Caucasian-vs-AfricanAmerican
9.170000E-01
Caucasian-vs-Asian
6.157300E-03
AfricanAmerican-vs-Asian
3.264000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.210600E-01
Normal-vs-Female
4.512600E-01
Male-vs-Female
3.054800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.518000E-01
Normal-vs-Age(41-60Yrs)
4.431600E-01
Normal-vs-Age(61-80Yrs)
4.307800E-01
Normal-vs-Age(81-100Yrs)
4.249000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.585400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.935600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.919000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.531400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.490600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.042800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.257200E-01
Normal-vs-Daily Drinker
4.049800E-01
Normal-vs-Weekly Drinker
3.720400E-01
Normal-vs-Occasional Drinker
4.052200E-01
Normal-vs-Social Drinker
4.313200E-01
Non Drinker-vs-Daily Drinker
6.704400E-01
Non Drinker-vs-Weekly Drinker
2.024400E-01
Non Drinker-vs-Occasional Drinker
6.616400E-01
Non Drinker-vs-Social Drinker
8.928600E-01
Daily Drinker-vs-Weekly Drinker
2.880400E-01
Daily Drinker-vs-Occasional Drinker
9.865400E-01
Daily Drinker-vs-Social Drinker
5.097000E-01
Weekly Drinker-vs-Occasional Drinker
2.359600E-01
Weekly Drinker-vs-Social Drinker
7.933500E-02
Occasional Drinker-vs-Social Drinker
4.614600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.975800E-01
Normal-vs-Grade 2
9.308000E-02
Normal-vs-Grade 3
7.846000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.441600E-01
Grade 1-vs-Grade 3
5.416800E-01
Grade 1-vs-Grade 4
3.975800E-01
Grade 2-vs-Grade 3
2.142600E-01
Grade 2-vs-Grade 4
9.308000E-02
Grade 3-vs-Grade 4
7.846000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.707000E-01
Normal-vs-NonDiabetic
4.016400E-01
Diabetic-vs-NonDiabetic
6.879600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.801400E-01
Normal-vs-NoPancreatitis
4.239600E-01
Pancreatitis-vs-NoPancreatitis
2.686400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.359400E-01
Normal-vs-N1
4.361200E-01
N0-vs-N1
9.706200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.718600E-01
Normal-vs-TP53-NonMutant
4.743000E-01
TP53-Mutant-vs-TP53-NonMutant
1.018040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
